Physician profile
Marvin Chadab
NPI 1376724583
$2,900.16
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,226 · 2020: $674.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $888.30 | 2019-2020 | |
| Encore Dermatology INC. | $309.64 | 2019-2020 | |
| Pfizer INC. | $276.52 | 2019-2020 | |
| Janssen Biotech, INC. | $191.44 | 2019-2020 | |
| Journey Medical Corporation | $163.59 | 2019 | |
| Lilly USA, LLC | $156.74 | 2019-2020 | |
| Celgene Corporation | $122.27 | 2019 | |
| Novartis Pharmaceuticals Corporation | $117.89 | 2019 | |
| Mayne Pharma Commercial LLC | $116.76 | 2019 | |
| Galderma Laboratories, L.P. | $113.56 | 2019 | |
| Janssen Scientific Affairs, LLC | $103.92 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $73.58 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $39.32 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $37.18 | 2019 | |
| Vyne Pharmaceuticals INC. | $36.27 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $26.24 | 2019 | |
| Sebela Pharmaceuticals INC. | $20.86 | 2019 | |
| Promius Pharma LLC | $20.50 | 2019 | |
| Dermira, INC. | $17.18 | 2019 | |
| Mission Pharmacal Company | $15.43 | 2019 | |
| Almirall LLC | $13.77 | 2019 | |
| Genzyme Corporation | $13.46 | 2019 | |
| Medimetriks Pharmaceuticals, INC. | $13.17 | 2019 | |
| Merck Sharp & Dohme LLC | $12.57 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marvin Chadab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.